OsteoRemedies Gains Expanded Indications for SPECTRUM GV

OsteoRemedies announced FDA clearance for expanded indications for SPECTRUM GV Bone Cement. The expanded indication covers the fixation of revision hip arthroplasty components, implanted in the second stage of a two-stage revision after the initial infection has been cleared.

Initially launched in 2018, SPECTRUM GV Bone Cement is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us